Stockreport

Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies

Simulations Plus, Inc.  (SLP) 
Last simulations plus, inc. earnings: 4/9 04:35 pm Check Earnings Report
US:NASDAQ Investor Relations: simulations-plus.com/software/overview
PDF Modeling and simulation will be a key component for shift to non-animal methodologiesIntroducing NAMVantage(TM), a flagship package offering PBPK and QSP professional se [Read more]